罗氏试剂盒说明书英文原版 proBNP II STAT 05390109190 V7.pdfVIP

ms_05390109190V7.0 proBNP II STAT N-terminal pro B-type natriuretic peptide, STAT (Short Turn Around Time) cobas e 601 190 100 cobas e 602 English fluid retention or volume overload (e.g. COX‑2 inhibitors, nonsteroidal Intended use anti‑inflammatory drugs).22,23,24,25,26,27,28,29,30,31,32,33 Immunoassay for the in vitro quantitative determination of N‑terminal pro The Elecsys proBNP II STAT assay contains two monoclonal antibodies B‑type natriuretic peptide in human serum and plasma. This assay is which recognize epitopes located in the N‑terminal part (1‑76) of proBNP indicated as an aid in the diagnosis of individuals suspected of having (1‑108). congestive heart failure and detection of mild forms of cardiac dysfunction.1, Test principle 2,3,4,5,6 The test also aids in the assessment of heart failure severity in Sandwich principle. Total duration of assay: 9 minutes. 7 patients diagnosed with congestive heart failure. This assay is further indicated for the risk stratification of patients with acute coronary syndrome ▪ During a 9 minutes incubation, antigen in the sample (15 µL), a and congestive heart failure, and it can also be used for monitoring the biotinylated monoclonal NT‑proBNP‑specific antibody, a monoclonal treatment in patients with left ventricular dysfunction.8,9